◆ TICKERBASEVisão interativa →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Início › Todas as ações › 4527 · English version

Rohto Pharmaceutical Co.,Ltd. (4527)

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Consumer Defensive · Wall Street (EUA) · Última atualização: 2026-10-02

Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods Japan, China, and internationally. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams.

Números-chave

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados2026-03-312025-03-312024-03-312023-03-312022-03-31
Receita totalJPY 343.7BJPY 308.6BJPY 270.8BJPY 238.7B—
Lucro brutoJPY 192.7BJPY 174.4BJPY 157.3BJPY 137.4B—
Resultado Operacional (EBIT)JPY 41.1BJPY 38.2BJPY 40.1BJPY 34.0B—
Resultado líquidoJPY 34.2BJPY 30.8BJPY 30.9BJPY 26.4B—

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 4527. /companies/us/4527

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.